Hematologic Malignancies: Clinical Trials

5 trials for Hematologic Malignancies, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 unknown. 5 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Unknown 5
Phase 22Unknown 2

Follow Hematologic Malignancies: new trials by email Literature Review of Hematologic Malignancies trials Research Report on Hematologic Malignancies

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of CN202 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors or Hematologic Malignancies
CN202 - Locally Advanced Solid Tumor, Metastatic Solid Tumor
Phase 1 / Phase 2UnknownCuron Biopharmaceutical (Australia) Co Pty Ltd1642021-10-222021-08-31
A Study to Assess the Effect of Venetoclax on Ethinyl Estradiol and Levonorgestrel in Female Participants With Different Hematological Malignancies
Venetoclax, ethinyl estradiol/levonorgestrel - Hematologic Malignancies
Phase 1UnknownAbbVie122019-07-302024-08-29
Study of a Humanized Antibody Initiated 2 Months After an HLA Matched Allogenic Stem Cell Transplantation
Monalizumab - Hematologic Malignancies
Phase 1UnknownInstitut Paoli-Calmettes182016-11-282018-09-19
A Study of HMPL-523 in Relapsed or Refractory Hematologic Malignancies
HMPL-523 - Hematologic Malignancies
Phase 1UnknownHutchison Medipharma Limited782015-11-012020-09-11
Umbilical Cord Derived Mesenchymal Stromal Cells For The Treatment of Severe Steroid-resistant Graft Versus Host Disease
UMBILICAL CORD DERIVED MESENCHYMAL STROMAL CELLS (UC-MSC) - Hematologic Malignancies
Phase 1 / Phase 2UnknownA.O. Ospedale Papa Giovanni XXIII472013-09-012019-01-18

Narrower conditions

Hematologic Neoplasms (5)  ·  Lymphoma, Non-Hodgkin (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasms (1)  ·  Recurrence (1)

Broader conditions

Hematologic Diseases (5)  ·  Hemic and Lymphatic Diseases (5)  ·  Neoplasms by Site (5)  ·  Neoplasms (4)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Disease Attributes (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Lymphatic Diseases (1)  ·  Lymphoma (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplastic Processes (1)

Interventions

Ethinyl Estradiol-Norgestrel Combination (1)  ·  monalizumab (1)  ·  venetoclax (1)

Sponsors

A.O. Ospedale Papa Giovanni XXIII (1)  ·  AbbVie (1)  ·  Curon Biopharmaceutical (Australia) Co Pty Ltd (1)  ·  Hutchison Medipharma Limited (1)  ·  Institut Paoli-Calmettes (1)

Countries

Australia (2)  ·  France (1)  ·  Italy (1)  ·  United States (1)

Top investigators

Alessandro Rambaldi, MD (1)  ·  Chen Yu, MD (1)  ·  Gary Richardson (1)  ·  Morteza Aghmesheh (1)

Results publications

PMID 16732175, PMID 18468541, PMID 18703664, PMID 18820709, PMID 20350611, PMID 21393326, PMID 21417678